Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups-Reference-Cited by-同舟云学术

Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups

Published:2015-08-10 Issue:12 Volume:62 Page:2125-2131
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Oberlin Odile¹,Rey Annie¹,Brown Kenneth L.B.²,Bisogno Gianni³,Koscielniak Ewa⁴,Stevens Michael C.G.⁵,Hawkins Douglas S.⁶,Meyer William H.⁷,La Trang H.⁸,Carli Modesto³,Anderson James R.⁹

Affiliation:

1. Departments of Pediatrics and Biostatistics; Institut Gustave Roussy; Villejuif France

2. Departments of Pediatric Orthopedic Surgery; British Columbia Children's Hospital; Vancouver British Columbia

3. Department of Pediatrics, Division of Hematology/Oncology; University Hospital of Padova; Padova Italy

4. Pediatric 5 (Oncology, Hematology, Immunolgy); Olga Hospital; Klinikum Stuttgart Germany

5. Department of Paediatric Oncology; Bristol Royal Hospital for Children; Bristol UK

6. Division of Hematology/Oncology, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center; University of Washington; Seattle Washington

7. Department of Pediatric Hematology/Oncology; University of Oklahoma Health Science Center; Oklahoma City Oklahoma

8. Radiation Oncology; Kaiser Permanente-Oakland; Oakland California

9. Department of Preventive and Societal Medicine; University of Nebraska Medical Center; Omaha Nebraska

Funder

National Cancer Institute

Cancer Research UK, Gustave Roussy, and Association Enfant et Santé, France - AIEOP-STSC

Fondazione Città della Speranzah

Cancer Research UK, Gustave Roussy, Association Enfant et Santé, France

Fondazione Città della Speranza

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference30 articles.

1. Long-term results in childhood rhabdomyosarcoma: A report from the Italian cooperative study RMS 79;Bisogno;Pediatr Blood Cancer,2012

2. Intergroup rhabdomyosarcoma study-IV: Results for patients with nonmetastatic disease;Crist;J Clin Oncol,2001

3. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults;Dantonello;J Clin Oncol,2009

4. Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: Long-term results from the International Society of Pediatric Oncology MMT95 study;Oberlin;J Clin Oncol,2012

5. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: Third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89;Stevens;J Clin Oncol,2005

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee;Pediatric Blood & Cancer;2024-09-03

2. Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside;Frontiers in Oncology;2024-02-02

3. Extremity Rhabdomyosarcoma—An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification;JCO Precision Oncology;2023-06

4. CDKAL1 Drives the Maintenance of Cancer Stem‐Like Cells by Assembling the eIF4F Translation Initiation Complex;Advanced Science;2023-02-14

5. Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001–2017;Cancer Medicine;2022-09-07